Hyperexcitability of the hippocampal neurons in the synaptic vesicle protein SV2A mutant rats

被引：0
|
作者：
Tokudome, Kentaro [1 ]
Okumura, Takahiro [1 ]
Shimizu, Saki [1 ]
Kunisawa, Naofumi [1 ]
Tomita, Chisato [1 ]
Kitaya, Ryosuke [1 ]
Mashimo, Tomoji [2 ]
Serikawa, Tadao [2 ]
Sasa, Masashi [3 ]
Ohno, Yukihiro [1 ]
机构：
[1] Osaka Univ Pharm Sci, Pharmacol Lab, Takatsuki, Osaka 5691094, Japan
[2] Kyoto Univ, Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan
[3] Nagisa Clin, Hirakata, Osaka 5731183, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2013年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：155P / 155P
页数：1
相关论文
共 50 条
  • [21] Targeting hippocampal amyloidogenesis with SV2A protein modulator levetiracetam
    Kasatkina, Ludmila A.
    Gumenyuk, Vitaliy P.
    Lisakovska, Olha O.
    Trikash, Irene O.
    BIOCHEMICAL PHARMACOLOGY, 2022, 197
  • [22] NEGATIVE MODULATION OF THE SYNAPTIC VESICLE PROTEIN (SV2A): A NEW PHARMACOLOGICAL TARGET FOR COGNITIVE DEFICIT ASSOCIATED WITH SCHIZOPHRENIA
    Laruelle, Marc
    Detrait, Eric
    Lamberty, Yves
    Leclercq, Karine
    Jnoff, Eric
    Wood, Martin
    Gillard, Michel
    Jigorel, Emilie
    Klitgaard, Henrik
    Provins, Laurent
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S66 - S66
  • [23] Negative Modulation of the Synaptic Vesicle Protein (SV2A): A New Pharmacological Target for Cognitive Deficit Associated with Schizophrenia
    Detrait, Eric R.
    Laruelle, Marc
    Lamberty, Yves
    Leclercq, Karine
    Jnoff, Eric
    Wood, Martyn
    Gillard, Michel
    Jigorel, Emilie
    Klitgaard, Henrik
    Provins, Laurent
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 133S - 133S
  • [24] Pathophysiological alterations of synaptic vesicle protein 2A (SV2A) in Groggy rat, a rat model of absence seizure.
    Okumura, Takahiro
    Ishihara, Shizuka
    Terada, Ryo
    Tomita, Chisato
    Kitaya, Ryosuke
    Tokudome, Kentarou
    Tanaka, Tomoya
    Shimizu, Saki
    Kawai, Yoshiko
    Serikawa, Tadao
    Sasa, Masashi
    Ohno, Yukihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 150P - 150P
  • [25] Synaptic Vesicle Glycoprotein 2A (SV2A) Levels as a Translatable Measure of Synaptic Density Following HDAC Inhibition
    Ivarsson, Magnus
    Quinton, Maria
    Lynch, Berkley
    McKee, Timothy
    Fuller, Nathan
    Rosenberg, Adam
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S45 - S46
  • [26] [11C]UCB-J PET imaging of synaptic vesicle protein SV2A in cognitive decline
    DiFilippo, Alexandra
    Tullis, Tyler
    Zammit, Matthew
    Murali, Dhanabalan
    McKinney, Grace
    Davenport, Nancy
    Barnhart, Todd
    Betthauser, Tobey
    Engle, Jonathan
    Stone, Charles
    Johnson, Sterling
    Bendlin, Barbara
    Christian, Bradley
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [27] Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein
    Gillard, M
    Chatelain, P
    Fuks, B
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 536 (1-2) : 102 - 108
  • [28] Synaptic Vesicle Protein 2 (SV2) Isoforms
    Bandala, Cindy
    Miliar-Garcia, A.
    Mejia-Barradas, C. M.
    Anaya-Ruiz, M.
    Luna-Arias, J. P.
    Bazan-Mendez, C. I.
    Gomez-Lopez, M.
    Juarez-Mendez, S.
    Lara-Padilla, E.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 5063 - 5067
  • [29] SYNAPTIC VESICLE PROTEIN 2A (SV2A) EXPRESSION IN EPILEPSY-ASSOCIATED BRAIN TUMORS AND IN THE PERILESIONAL EPILEPTIC CORTEX
    Aronica, E.
    Toering, S.
    Boer, K.
    Heimans, J.
    Reijneveld, J.
    EPILEPSIA, 2009, 50 : 89 - 89
  • [30] Synaptic vesicle Protein 2 (SV2) modulates synaptic exoytosis
    Bajjalieh, SM
    Mochida, S
    Zeigerer, A
    Nelson, C
    Schivell, A
    Capati, C
    Fukuda, M
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 428A - 428A
12345